11-65884053-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004214.5(FIBP):c.1005-10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000544 in 1,611,750 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )
Consequence
FIBP
NM_004214.5 intron
NM_004214.5 intron
Scores
2
Splicing: ADA: 0.0004652
2
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
FIBP (HGNC:3705): (FGF1 intracellular binding protein) Acidic fibroblast growth factor is mitogenic for a variety of different cell types and acts by stimulating mitogenesis or inducing morphological changes and differentiation. The FIBP protein is an intracellular protein that binds selectively to acidic fibroblast growth factor (aFGF). It is postulated that FIBP may be involved in the mitogenic action of aFGF. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-65884053-C-T is Benign according to our data. Variant chr11-65884053-C-T is described in ClinVar as [Benign]. Clinvar id is 785815.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00261 AC: 398AN: 152216Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
398
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000727 AC: 179AN: 246274 AF XY: 0.000653 show subpopulations
GnomAD2 exomes
AF:
AC:
179
AN:
246274
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000326 AC: 476AN: 1459416Hom.: 0 Cov.: 31 AF XY: 0.000296 AC XY: 215AN XY: 725882 show subpopulations
GnomAD4 exome
AF:
AC:
476
AN:
1459416
Hom.:
Cov.:
31
AF XY:
AC XY:
215
AN XY:
725882
Gnomad4 AFR exome
AF:
AC:
283
AN:
33440
Gnomad4 AMR exome
AF:
AC:
59
AN:
44562
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26038
Gnomad4 EAS exome
AF:
AC:
0
AN:
39660
Gnomad4 SAS exome
AF:
AC:
1
AN:
85826
Gnomad4 FIN exome
AF:
AC:
0
AN:
53338
Gnomad4 NFE exome
AF:
AC:
68
AN:
1110490
Gnomad4 Remaining exome
AF:
AC:
65
AN:
60296
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00263 AC: 400AN: 152334Hom.: 3 Cov.: 32 AF XY: 0.00251 AC XY: 187AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
400
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
187
AN XY:
74484
Gnomad4 AFR
AF:
AC:
0.00860949
AN:
0.00860949
Gnomad4 AMR
AF:
AC:
0.00209096
AN:
0.00209096
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000441021
AN:
0.0000441021
Gnomad4 OTH
AF:
AC:
0.00331439
AN:
0.00331439
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at